List of Doral drug patents

Doral is owned by Galt Pharms.

Doral contains Quazepam.

Doral has a total of 1 drug patent out of which 0 drug patents have expired.

Doral was authorised for market use on 27 December, 1985.

Doral is available in tablet;oral dosage forms.

Doral can be used as method for treating insomnia while reducing the risk of an adverse drug interaction.

The generics of Doral are possible to be released after 03 June, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7608616 GALT PHARMS Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
Jun, 2028

(5 years from now)

Drugs and Companies using QUAZEPAM ingredient

Market Authorisation Date: 27 December, 1985

Treatment: Method for treating insomnia while reducing the risk of an adverse drug interaction

Dosage: TABLET;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in